Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 15, 2021

SELL
$13.71 - $17.18 $61,695 - $77,310
-4,500 Closed
0 $0
Q3 2020

Nov 06, 2020

SELL
$3.29 - $4.58 $4,349 - $6,054
-1,322 Reduced 22.71%
4,500 $17,000
Q2 2020

Aug 26, 2020

BUY
$2.86 - $4.61 $12,870 - $20,745
4,500 Added 340.39%
5,822 $22,000
Q4 2019

Feb 12, 2020

BUY
$4.7 - $8.11 $6,213 - $10,721
1,322 New
1,322 $6,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $505M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.